Joshua S. Prince

Insider Reports History

Entity
Individual
Location
C/O Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua S. Prince:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Chief Operating Officer Common Stock 2.67K $7.9K $2.96 Jun 28, 2024 Direct
Vistagen Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 150K Jun 24, 2024 Direct

Insider Reports Filed by Joshua S. Prince

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN Vistagen Therapeutics, Inc. Jun 28, 2024 1 $7.9K 4 Jul 2, 2024 Chief Operating Officer
VTGN Vistagen Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 Chief Operating Officer
VTGN Vistagen Therapeutics, Inc. Oct 24, 2023 0 $0 3 Nov 3, 2023 Chief Operating Officer